Bayer AG (WAR:BAY) FFO


WAR:BAY Bayer AG WAR:BAY
44 GF Score
Price zł198.20
GF Value zł116.22
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG FFO?

FFO (Funds from operations) only applies to REITs.

WAR:BAY
44GF Score
Bayer AG WAR:BAY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł198.20 is trading 70.5% above its estimated GF Value™ of zł116.22. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • FFO:
  • GF Value™: zł116.22 vs. price of zł198.20 (70.5% above fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
44GF Score

Get the complete analysis for WAR:BAY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł198.20
Price
zł116.22
GF Value